Epoch Investment Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $80.2M | Buy |
2,854,601
+425,669
| +18% | +$11.3M | 0.49% | 82 |
|
|
2025
Q4 | $60.5M | Buy |
2,428,932
+505,361
| +26% | +$12.7M | 0.34% | 111 |
|
|
2025
Q3 | $49M | Sell |
1,923,571
-48,472
| -2% | -$1.2M | 0.27% | 133 |
|
|
2025
Q2 | $47.8M | Sell |
1,972,043
-156,377
| -7% | -$3.65M | 0.25% | 139 |
|
|
2025
Q1 | $53.9M | Buy |
2,128,420
+59,811
| +3% | +$1.57M | 0.28% | 137 |
|
|
2024
Q4 | $54.9M | Sell |
2,068,609
-211,933
| -9% | -$5.75M | 0.27% | 142 |
|
|
2024
Q3 | $66M | Buy |
2,280,542
+412,798
| +22% | +$12M | 0.3% | 133 |
|
|
2024
Q2 | $52.3M | Sell |
1,867,744
-40,732
| -2% | -$1.12M | 0.24% | 147 |
|
|
2024
Q1 | $53M | Sell |
1,908,476
-125,520
| -6% | -$3.48M | 0.24% | 154 |
|
|
2023
Q4 | $58.6M | Sell |
2,033,996
-903,333
| -31% | -$27.3M | 0.27% | 146 |
|
|
2023
Q3 | $97.4M | Buy |
2,937,329
+9,507
| +0.3% | +$336K | 0.62% | 45 |
|
|
2023
Q2 | $107M | Buy |
2,927,822
+112,113
| +4% | +$4.36M | 0.62% | 43 |
|
|
2023
Q1 | $115M | Buy |
2,815,709
+260,153
| +10% | +$11.2M | 0.68% | 36 |
|
|
2022
Q4 | $131M | Sell |
2,555,556
-36,825
| -1% | -$1.77M | 0.78% | 33 |
|
|
2022
Q3 | $113M | Sell |
2,592,381
-147,213
| -5% | -$7.15M | 0.74% | 34 |
|
|
2022
Q2 | $144M | Sell |
2,739,594
-160,101
| -6% | -$8.16M | 0.84% | 27 |
|
|
2022
Q1 | $150M | Buy |
2,899,695
+217,580
| +8% | +$11.3M | 0.74% | 33 |
|
|
2021
Q4 | $158M | Sell |
2,682,115
-804,761
| -23% | -$39.9M | 0.8% | 31 |
|
|
2021
Q3 | $150M | Sell |
3,486,876
-252,027
| -7% | -$11.2M | 0.83% | 28 |
|
|
2021
Q2 | $146M | Sell |
3,738,903
-562,299
| -13% | -$21.9M | 0.79% | 35 |
|
|
2021
Q1 | $156M | Sell |
4,301,202
-6,043
| -0.1% | -$215K | 0.73% | 41 |
|
|
2020
Q4 | $159M | Sell |
4,307,245
-427,961
| -9% | -$15.7M | 0.73% | 45 |
|
|
2020
Q3 | $165M | Sell |
4,735,206
-624,027
| -12% | -$21.9M | 0.82% | 34 |
|
|
2020
Q2 | $166M | Sell |
5,359,233
-5,635,018
| -51% | -$191M | 0.86% | 29 |
|
|
2020
Q1 | $340M | Buy |
10,994,251
+350,145
| +3% | +$11.9M | 2.06% | 4 |
|
|
2019
Q4 | $396M | Buy |
10,644,106
+254,049
| +2% | +$9.05M | 1.71% | 5 |
|
|
2019
Q3 | $354M | Buy |
10,390,057
+967,813
| +10% | +$35.2M | 1.61% | 6 |
|
|
2019
Q2 | $387M | Sell |
9,422,244
-701,444
| -7% | -$27.9M | 1.75% | 3 |
|
|
2019
Q1 | $408M | Buy |
10,123,688
+133,169
| +1% | +$5.33M | 1.78% | 4 |
|
|
2018
Q4 | $414M | Sell |
9,990,519
-1,092,274
| -10% | -$45.3M | 1.92% | 4 |
|
|
2018
Q3 | $463M | Sell |
11,082,793
-1,951,719
| -15% | -$75.1M | 1.76% | 6 |
|
|
2018
Q2 | $449K | Sell |
13,034,512
-710,294
| -5% | -$24.3M | 1.39% | 8 |
|
|
2018
Q1 | $463M | Buy |
13,744,806
+673,135
| +5% | +$23.1M | 1.64% | 11 |
|
|
2017
Q4 | $449M | Sell |
13,071,671
-144,433
| -1% | -$4.92M | 1.49% | 13 |
|
|
2017
Q3 | $448M | Buy |
13,216,104
+4,048,234
| +44% | +$130M | 1.5% | 12 |
|
|
2017
Q2 | $292M | Buy |
9,167,870
+2,009,546
| +28% | +$63.4M | 0.99% | 34 |
|
|
2017
Q1 | $232M | Buy |
7,158,324
+3,307,416
| +86% | +$104M | 0.78% | 48 |
|
|
2016
Q4 | $119M | Buy |
3,850,908
+23,251
| +0.6% | +$710K | 0.45% | 87 |
|
|
2016
Q3 | $123M | Buy |
3,827,657
+106,178
| +3% | +$3.55M | 0.46% | 84 |
|
|
2016
Q2 | $124M | Buy |
3,721,479
+163,689
| +5% | +$5.22M | 0.47% | 79 |
|
|
2016
Q1 | $100M | Sell |
3,557,790
-4,187
| -0.1% | -$120K | 0.38% | 89 |
|
|
2015
Q4 | $109M | Sell |
3,561,977
-48,527
| -1% | -$1.53M | 0.43% | 77 |
|
|
2015
Q3 | $108M | Buy |
3,610,504
+319,735
| +10% | +$10.3M | 0.42% | 84 |
|
|
2015
Q2 | $105M | Buy |
3,290,769
+3,275,339
| +21,227% | +$107M | 0.39% | 89 |
|
|
2015
Q1 | $510K | Buy |
15,430
+3,965
| +35% | +$126K | ﹤0.01% | 260 |
|
|
2014
Q4 | $339K | Buy |
11,465
+4,120
| +56% | +$118K | ﹤0.01% | 264 |
|
|
2014
Q3 | $206K | Buy |
+7,345
| New | +$206K | ﹤0.01% | 276 |
|
|
2014
Q1 | – | Sell |
-1,019,402
| Closed | -$29.6M | – | 282 |
|
|
2013
Q4 | $29.6M | Buy |
1,019,402
+4,732
| +0.5% | +$138K | 0.13% | 143 |
|
|
2013
Q3 | $27.7M | Buy |
1,014,670
+39,319
| +4% | +$1.07M | 0.12% | 137 |
|
|
2013
Q2 | $25.9M | Buy |
+975,351
| New | +$26.9M | 0.13% | 136 |
|
Other funds holding PFE
VCM
VPM
Epoch Investment Partners's PFE Position: Q1 2026 in Review
Epoch Investment Partners increased its Pfizer (PFE) stake by 18% in Q1 2026, buying an estimated $11.3M and bringing the position to 2,854,601 shares worth $80.2M. The position accounts for 0.49% of the portfolio, ranked #82.
Epoch Investment Partners first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $463M in Q3 2018. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Epoch Investment Partners held 2,854,601 shares of Pfizer worth $80.2M as of Q1 2026.
- Epoch Investment Partners bought 425,669 Pfizer shares in Q1 2026, an estimated $11.3M.
- Pfizer made up 0.49% of Epoch Investment Partners's portfolio in Q1 2026, its #82 holding.
- Epoch Investment Partners first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
- Epoch Investment Partners's Pfizer position peaked at $463M in Q3 2018.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Epoch Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.